Effects of Exercise Training on Exercise Capacity and Sleep Quality in Patients With Obesity Hypoventilation Syndrome
Launched by ISTANBUL UNIVERSITY · May 27, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how exercise training can improve both exercise capacity and sleep quality in patients with Obesity Hypoventilation Syndrome (OHS). OHS is a condition where people struggle to breathe properly during sleep, often due to obesity, leading to symptoms like feeling suffocated, loud snoring, morning headaches, and excessive daytime sleepiness. The researchers want to find out if aerobic (like walking or cycling) and strength training can help these patients feel better and improve their overall quality of life.
To participate in the trial, individuals must be over 18 years old and have a diagnosis of Obesity Hypoventilation Syndrome. However, those currently on other diet programs, with serious respiratory or other health issues, or who have conditions preventing them from exercising safely will not be eligible. Participants can expect to engage in a structured exercise program and will be monitored throughout the study to assess improvements in their physical abilities, sleep quality, muscle strength, emotional well-being, and overall health. This research aims to provide valuable insights that could lead to better treatment options for people with OHS.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • \>18 years old
- • Patients who have been diagnosed with Obesity Hypoventilation Syndrome
- Exclusion Criteria:
- • Patients who participate in any other diet program
- • Patients who are incompatible with a diet program or exercise program
- • Patients with uncontrollable respiratory and comorbid diseases
- • Patient who have been an orthopedic, neurological, cardiac, or metabolic condition that may prevent participation and continuation of the exercise program throughout the study
About Istanbul University
Istanbul University, a leading institution in Turkey, is dedicated to advancing healthcare through rigorous clinical research and education. Renowned for its commitment to scientific excellence and innovation, the university sponsors clinical trials that aim to enhance medical knowledge and improve patient outcomes. With a diverse team of researchers and healthcare professionals, Istanbul University fosters collaboration across disciplines to explore new therapeutic interventions and contribute to global health advancements. Its robust infrastructure and ethical standards ensure the highest quality in clinical trial management, making it a key player in the field of medical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials